Cel Sci (CVM) Share-based Compensation (2010 - 2026)
Cel Sci's Share-based Compensation came in at $454,094 for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 518.3% from $73,441 a year earlier and up 0.6% from the prior quarter.
Powered by 
Analysis
Cel Sci (CVM) Share-based Compensation (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Cel Sci reported Share-based Compensation of $1.79 million, down 18.5% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $1.91 million, down 55.2% from FY2024.
- Share-based Compensation has declined in each of the last four fiscal years, with a five-year compound annual growth rate of -28.3% (FY2020 to FY2025).
- Going back by fiscal year, Share-based Compensation was $4.27 million in FY2024 (-32.1%), $6.29 million in FY2023 (-44.8%), $11.39 million in FY2022 (-16.8%) and $13.69 million in FY2021 (+35.3%).
- The fiscal Q3 2026 figure represents the highest quarterly Share-based Compensation since fiscal Q2 2025.
- Year-over-year, Share-based Compensation increased in 1 of the last seven quarters, with growth averaging 32.0%.
- The fastest year-over-year change in Share-based Compensation over five years came in fiscal Q3 2026 (growth of 518.3%), and the weakest in fiscal Q3 2025 (a decline of 89.9%).
- Business Quant data shows CVM's Share-based Compensation at $451,381 (Q2 2026), $443,275 (Q1 2026) and $440,506 (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Cel Sci | 3.11 Mn | -22.54 Mn | - | 454,094.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 454,094.00 |
| Mar 31, 2026 | 451,381.00 |
| Dec 31, 2025 | 443,275.00 |
| Sep 30, 2025 | 440,506.00 |
| Jun 30, 2025 | 73,441.00 |
| Mar 31, 2025 | 685,669.00 |
| Dec 31, 2024 | 711,381.00 |
| Sep 30, 2024 | 725,611.00 |
| Jun 30, 2024 | 728,120.00 |
| Mar 31, 2024 | 1.43 Mn |
| Dec 31, 2023 | 1.38 Mn |
| Sep 30, 2023 | 1.31 Mn |
| Jun 30, 2023 | 1.54 Mn |
| Mar 31, 2023 | 1.74 Mn |
| Dec 31, 2022 | 1.69 Mn |
| Sep 30, 2022 | 2.29 Mn |
| Jun 30, 2022 | 2.45 Mn |
| Mar 31, 2022 | 3.39 Mn |
| Dec 31, 2021 | 3.26 Mn |
| Sep 30, 2021 | 3.59 Mn |
API Access
Cel Sci Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CVM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "CVM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CVM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();